2 months Zacks Research Comments on AbbVie’s Q3 Earnings (NYSE:ABBV) MarketBeat
AbbVie Inc. (NYSE:ABBV – Free Report) – Stock analysts at Zacks Research cut their Q3 2024 earnings estimates for shares of AbbVie in a report released on Thursday, October 17th. Zacks Research analyst S. Ganoria now forecasts that the company will …
AbbVie (ABBV) · Earnings · NYSE · Science
X